We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

144:HKEXGiken Holdings Co., Ltd. Analysis

Data as of 2026-05-26 - not real-time

NT$12.30

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Chia Her Industrial is trading at TWD 12.3, just above its 20‑day SMA of 12.93 but below the 50‑day SMA of 13.09, indicating a neutral price trend. The RSI of 42 shows the stock is neither overbought nor oversold, while a bearish MACD (line below signal) and decreasing volume suggest short‑term pressure near the support level of 12.1.
Fundamentally, the company carries a trailing P/E of 102.5 and negative operating margins, compounded by a high debt‑to‑equity ratio of 113% and negative operating cash flow, which raise concerns about profitability. However, the market is pricing in a turnaround with a forward P/E of 6.1 and projected EPS rising to 2.02, while a low price‑to‑book of 0.68 and price‑to‑sales of 0.56 suggest relative cheapness on a balance‑sheet basis.
Risk factors are pronounced: 30‑day volatility exceeds 45%, beta is modest at 0.53, and the consumer‑cyclical textile sector is sensitive to economic swings. Geographic exposure to Taiwan adds medium geopolitical risk, and liquidity is constrained by decreasing volume. Investors should hold in the near term while watching for a breakout above the resistance of 14.5 and for the forward earnings outlook to materialize.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering near technical support
  • Bearish MACD and decreasing volume
  • Extremely high trailing P/E and negative cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward earnings expectations (EPS 2.02, forward P/E 6.1)
  • High debt burden limiting operational flexibility
  • Low price-to-book and price-to-sales offering value cushion

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Potential turnaround reflected in forward valuation metrics
  • Undervalued balance‑sheet ratios (P/B 0.68, P/S 0.56)
  • Strategic diversification into protective fabrics and medical masks

Key Metrics & Analysis

Financial Health

Revenue Growth22.30%
Profit Margin-1.22%
P/E Ratio102.5
ROE5.47%
ROA-3.08%
Debt/Equity113.29
P/B Ratio0.7
Op. Cash FlowNT$-209944992
Free Cash FlowNT$27.8M

Technical Analysis

TrendNeutral
RSI41.7
SupportNT$12.10
ResistanceNT$14.50
MA 20NT$12.93
MA 50NT$13.09
MA 200NT$11.75
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta0.53
Volatility45.25%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.